Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Ropivacaine with Butorphanol or Dexmedetomidine: Group RB: Intrathecal 0.75% hyperbaric ropivacaine 3.5 ml + butorphanol 100 mcg (0.1 ml) Group RD: Intrathecal 0.75% hyperbaric ropivaca
Sponsors
School of Medical Sciences and Research and Sharda Hospital Greater Noida
Eligibility
Inclusion criteria
Inclusion criteria: Patients scheduled for infraumbilical surgery under subarachnoid block. ASA Physical Status Grade I and II. Age between 18 to 60 years. Both male and female patients.
Exclusion criteria
Exclusion criteria: Morbid obesity Patient with history of adverse response to study drugs Patient with pre-existing neurological or spinal disease, cardiovascular disease, renal, hepatic or any other systemic disease Contraindications for spinal anaesthesia like: Raised ICP, local site infections & spinal deformities like kyphosis and scoliosis Pregnant females Coagulopathy or bleeding diathesis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of onset of sensory and motor blockade (assessed using pinprick method and Modified Bromage scale respectively)Timepoint: Every 1 minute until complete onset, then monitored intraoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the duration of sensory and motor blockade assessed by pin prick, Visual Analog Score (VAS) and modified Bromage scale respectively. Changes in vitals parameters-heart rate (HR), noninvasive blood pressure (NIBP), and oxygen saturation (SPO2) intra operatively. Requirement of first rescue analgesic in postoperative period in the first 24 hours.Timepoint: Assessed every 1 min until onset, then every 10 min post 2 hours until full recovery Baseline, then every 5 minutes intraoperatively and every 15 minutes post-op for 3 hours Monitored continuously up to 24 hours post-op | — |
Countries
India
Contacts
Public ContactDr Apurva Tandon
School of Medical Sciences and Research Sharda University
Outcome results
None listed